Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Otsuka_Pharmaceutical
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:foundedYear |
2001
|
| gptkbp:founder |
gptkb:Andrew_Thompson
|
| gptkbp:headquartersLocation |
gptkb:Redwood_City,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Proteus Digital Health
|
| gptkbp:industry |
gptkb:insurance
digital medicine |
| gptkbp:keyPerson |
gptkb:Andrew_Thompson
gptkb:George_Savage Mark Zdeblick |
| gptkbp:notableFor |
FDA-approved digital pill
developing digital pills |
| gptkbp:product |
digital medicine platform
ingestible sensor |
| gptkbp:status |
filed for bankruptcy in 2020
|
| gptkbp:website |
https://www.proteus.com/
|
| gptkbp:bfsParent |
gptkb:Nancy_Dougherty
|
| gptkbp:bfsLayer |
6
|